MUC1 and prostate carcinoma: Other prostate cancer antigens such as prostate cancer stem cell (CSC), HER2, and Mucin-1 as well as various receptors are ideal targets for prostate cancer treatment as well, but fewer studies have been performed to develop such targeted delivery systems [131].